Skip to content

Fire needle plus cupping on pain improvement in patients with herpes zoster: a randomized controlled trial

Fire needle plus cupping on pain improvement in patients with herpes zoster: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100054148
Enrollment
Unknown
Registered
2021-12-10
Start date
2021-12-15
Completion date
Unknown
Last updated
2022-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Herpes zoster

Interventions

Sponsors

Beijing Traditional Chinese Medicine Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged over 18 years old; 2. Meet the diagnostic criteria for herpes zoster in the 2018 Chinese Medical Doctor Association Dermatologist Branch Herpes Zoster Expert Consensus Working Group "Chinese Expert Consensus on Herpes Zoster"; 3. Within 6 days after the rash of herpes zoster; 4. The average VAS of the highest daily pain after the rash is greater than or equal to 3; 5. The patients themselves signed the informed consent to participate in this trial voluntarily.

Exclusion criteria

Exclusion criteria: 1. Combined with serious primary diseases such as cardiovascular and cerebrovascular, liver, kidney and hematopoietic system and other organic diseases such as tumors; 2. Patients with mental disorders such as depression and anxiety who need to take tricyclic antidepressants, and those with mental or intellectual disabilities who cannot cooperate with the questionnaire; 3. Patients with bleeding tendency, pain-related skin disease or scar constitution; 4. Pregnant women and lactating women, those who have childbearing requirements in the past six months; 5. Known immunodeficiency status or history of HIV infection, positive history of hepatitis B antigen or hepatitis C antibody, active pulmonary tuberculosis, or using corticosteroids or immunosuppressants for 1 month; 6. Poor blood sugar control, glycosylated hemoglobin >= 8.0%; 7. Patients with coagulation dysfunction, or taking antiplatelet and anticoagulant drugs; 8. Received acupuncture treatment within the past 1 week; 9. Belongs to a special type of herpes zoster: eye, ear herpes zoster, abrupt herpes zoster, herpes zoster without rash, herpes zoster meningitis or encephalitis, herpes zoster invading visceral nerve fibers, disseminated zona Herpes zoster and others (herpes zoster with bullous, hemorrhagic, gangrenous and other manifestations); 10. Those who are participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
VAS responder rate(>=30%);

Countries

China

Contacts

Public ContactLi Bin

Beijing Traditional Chinese Medicine Hospital Affiliated to Capital Medical University

libin@bjzhongyi.com+86 18910781852

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026